Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Novartis |
Recipient: You |
Company: CVS Caremark |
Recipient: You |
Company: Epizyme |
Recipient: You |
Company: Actinium Pharmaceuticals |
Recipient: You |
Company: SERVIER |
Recipient: You |
Company: Immunogen |
Recipient: You |
Company: Kling Biotherapeutics |
Recipient: You |
Company: Curis |
Recipient: You |
Company: Jazz |
Recipient: You |
Company: AbbVie |
Recipient: You |
Company: Takeda Science Foundation |
Recipient: You |
Company: Rigel Pharmaceuticals |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Gilead/Forty Seven |
Recipient: You |
Company: Daiichi Sankyo |
Recipient: Your Institution |
Company: Celgene |
Recipient: Your Institution |
Company: Astellas Pharma |
Recipient: Your Institution |
Company: Novartis |
Recipient: Your Institution |
Company: Rafael Pharmaceuticals |
Recipient: Your Institution |
Company: Cellectis |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
Please describe: UpToDate, Inc |
Recipient: You |
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
No Relationships to Disclose |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|